Is brivaracetam/brivaracetam necessary for long-term use in the treatment of epilepsy?

Brivaracetam is a new anti-epileptic drug mainly used to treat partial-onset epilepsy. It modulates neuronal excitability by selectively binding to synaptic vesicle protein 2A (SV2A), thereby stabilizing nerve signaling. For epilepsy, a neurological disease with chronic relapsing characteristics, whether brivaracetam needs long-term use has become a concern for many patients.

Epilepsy is not a temporary disease. After diagnosis, most patients need to receive long-term anti-epileptic treatment to prevent repeated attacks and reduce the risk of brain damage. As a maintenance treatment drug, Brivaracetam's mechanism determines that it cannot "cure" epilepsy itself, but can help control seizure frequency and improve quality of life. Therefore, unless the dose is gradually reduced under the guidance of a doctor and after a sufficient observation period without seizures, it is generally not recommended to discontinue the drug without authorization or use it for a short period of time. Many patients can achieve significant seizure reduction or even clinical remission under brivaracetam treatment, but this does not mean that the epileptic lesions have been eradicated. Hasty discontinuation of the drug may lead to a rebound of the disease or even more severe epileptic seizures.

In addition, for children or young patients with epilepsy, doctors will comprehensively evaluate whether to try to reduce or discontinue medication based on development, neuroelectrographic performance, and disease course control. However, this usually requires at least seizure-free records for at least 2 years, and is decided after comprehensive electroencephalogram and clinical evaluation. For patients whose partial seizures are refractory or who have other neurological problems, long-term maintenance therapy may be the only option to avoid recurring attacks.

Compared with traditional anti-epileptic drugs, brivaracetam has milder side effects, fewer drug interactions, and better tolerance, making it more suitable for long-term use.

Reference materials:https://www.briviact.com/